Provost and Professor of Biochemistry
Steve A. N. Goldstein '78, M.A., M.D., Ph.D., F.A.A.P.
Steve A. N. Goldstein became provost of Brandeis University on September 1, 2011 and serves as the chief academic officer and the second ranking member of the administration, responsible for all areas of the university.
Working closely with President Frederick M. Lawrence, the Provost provides leadership for institutional strategic planning, educational activities and research initiatives. Through his oversight of institutional planning and budgets, he assures that financial and human resources are aligned with the university’s mission. The Provost is responsible for fostering a community devoted to shared learning, reflection and civil engagement; for optimizing the student experience and faculty scholarship and research; and for underscoring and advancing the university’s historic commitment to social justice.
The Office of Provost manages operations through the Provost’s Cabinet, the Deans’ Council, the University Advisory Council, the Institutional Planning and Budget Committee, the Diversity Committee, and ad hoc committees. Also reporting directly to the Provost are the Chief Information Officer, the Dean of Academic Services, the Director of the Rose Art Museum, the Director of the Office of the Arts, the Registrar, the Vice President for Global Affairs, and directors of university centers and institutes.
Goldstein grew up in New York City and came to Brandeis in 1974 as an undergraduate. He earned B.A. and M.A. degrees in biochemistry in 1978, graduating Phi Beta Kappa. Goldstein holds an M.D. and Ph.D. in immunology from Harvard University and is an accomplished scientist and scholar.
He is a leading authority on mechanisms underlying normal function of the heart and brain and sudden, life-threatening diseases. He did his pediatric internship, residency and a clinical fellowship in pediatric medicine and cardiology at Children’s Hospital Boston.
From 1993 to 2004, Goldstein was on the faculty at the Yale University School of Medicine and founded the Section of Developmental Biology and Biophysics. In 2004, he moved to the University of Chicago to become Chair of the Department of Pediatrics and Physician-in-Chief at Comer Children’s Hospital. While at Chicago he founded the Institute for Molecular Pediatric Sciences and co-founded the Institute for Translational Medicine. He is a fellow of the American Academy of Pediatrics and in 2001 received the E. Mead Johnson Award for pediatric research. From 2002 to 2007, he was editor-in-chief of the Quarterly Review of Biophysics.